Episurf Medical converts SEK 46.87 million of debt into 1,041,561,688 shares

• Episurf Medical resolved to pay accrued interest on Frusipe-related promissory notes by issuing 40,960,295 Class B shares at SEK 0.045.
• Holders converted convertibles with a nominal amount of SEK 46,870,276 into 1,041,561,688 Class B shares at SEK 0.045.
• New convertibles issued to Frusipe, convertible into 1,439,555,555 Class B shares at SEK 0.045, tied to the Hudiksvall Portfolio closing.
• Separate convertibles issued to EP Logistik, convertible into 252,670,822 Class B shares at SEK 0.045, via set-off of a claim.
• Share issue plus conversion lifts shares outstanding to 16,074,358,496, implying about 6.73% dilution; full conversion implies about 15.62%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Episurf Medical AB published the original content used to generate this news brief via Cision (Ref. ID: 20261001:BIT:8189:0) on October 01, 2026, and is solely responsible for the information contained therein.